Understanding the Comorbidities: Psoriasis and Metabolic Syndrome

A panel of experts lead by Dr. Peter Salgo, MD, discuss the increased risk of developing metabolic syndrome in patients with psoriasis and the treatment options available.

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Treatment Landscape and Final Thoughts
December 10, 2019 – 
The KOLs discuss the evolving treatment landscape and share their final thoughts.
Studies of Biologics on Cardiovascular Outcomes and Cost
December 03, 2019 – 
The panel discuss the studies looking at treating patients with biologics even in patients with comorbidities.
Understanding Plan B vs Plan D Coverage
December 03, 2019 – 
A review of the Plan B and Plan D insurance coverage and the products that are covered differently based on administration.
Dosing Impact on Patient Adherence and Patient Preference
November 26, 2019 – 
Panelists discuss the impact of dosing schedules on patient adherence and preference.
Improving Patient Adherence
November 26, 2019 – 
A discussion on patient adherence and how to help improve compliance.
IL-23: Long-term Data and Safety Data
November 19, 2019 – 
A review of the IL-23 inhibitors and their long-term and safety data.
Decreased Efficacy, PASI Score vs BSA, and Nonresponders
November 19, 2019 – 
The panel discusses the potential for decreased efficacy of treatment based on comorbidities. They also discuss the use of PASI score vs BSA to determine severity of disease and the need to identify responders and nonresponders to specific agents.
Comorbidities and Changes in Treatment Plan
November 12, 2019 – 
Experts delve into their treatment plan based on additional comorbidities patients may have.
Patient Preferences and Payer Approval of Treatment
November 12, 2019 – 
A discussion on the patient preference for specific medications based on administration and dosing schedule, and the payer approval process.
Identifying the Differing Mechanisms of Available Biologics
November 05, 2019 – 
The panel provides an understanding of the different biologics and the various mechanisms of action.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.